BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 32124117)

  • 41. Vasospasm on transcranial Doppler is predictive of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
    Kumar G; Shahripour RB; Harrigan MR
    J Neurosurg; 2016 May; 124(5):1257-64. PubMed ID: 26495942
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lessons Learned from Phase II and Phase III Trials Investigating Therapeutic Agents for Cerebral Ischemia Associated with Aneurysmal Subarachnoid Hemorrhage.
    Qureshi AI; Lobanova I; Huang W; Ishfaq MF; Broderick JP; Cassarly CN; Martin RH; Macdonald RL; Suarez JI
    Neurocrit Care; 2022 Apr; 36(2):662-681. PubMed ID: 34940927
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and Safety of Clazosentan After Aneurysmal Subarachnoid Hemorrhage: An Updated Meta-Analysis.
    Pontes JPM; Santos MDC; Gibram FC; Rodrigues NMV; Cavalcante-Neto JF; Barros ADM; Solla DJF
    Neurosurgery; 2023 Dec; 93(6):1208-1219. PubMed ID: 37462365
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does Nimodipine Interruption due to High Catecholamine Doses Lead to a Greater Incidence of Delayed Cerebral Ischemia in the Setting of Aneurysmal Subarachnoid Hemorrhage?
    Hernández-Durán S; Mielke D; Rohde V; Malinova V
    World Neurosurg; 2019 Dec; 132():e834-e840. PubMed ID: 31404696
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Survey of clinical experience with nimodipine in patients with subarachnoid hemorrhage.
    Tettenborn D; Porto L; Ryman T; Strugo V; Taquoi G; Battye R
    Neurosurg Rev; 1987; 10(2):77-84. PubMed ID: 3329302
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)].
    Hänggi D; Etminan N; Mayer SA; Aldrich EF; Diringer MN; Schmutzhard E; Faleck HJ; Ng D; Saville BR; Macdonald RL;
    Neurocrit Care; 2019 Feb; 30(1):88-97. PubMed ID: 30014184
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness of intrathecal nicardipine on cerebral vasospasm in non-traumatic subarachnoid hemorrhage: a systematic review.
    Stuart D; Christian R; Uschmann H; Palokas M
    JBI Database System Rev Implement Rep; 2018 Oct; 16(10):2013-2026. PubMed ID: 30335041
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of cilostazol-nimodipine combined therapy on delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage: a prospective, randomised, double-blinded, placebo-controlled trial protocol.
    Dawley T; Claus CF; Tong D; Rajamand S; Sigler D; Bahoura M; Garmo L; Soo TM; Kelkar P; Richards B
    BMJ Open; 2020 Oct; 10(10):e036217. PubMed ID: 33020083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Side effects of continuous intra-arterial infusion of nimodipine for management of resistant cerebral vasospasm in subarachnoid hemorrhage patients: A systematic review.
    Viderman D; Sarria-Santamera A; Bilotta F
    Neurochirurgie; 2021 Sep; 67(5):461-469. PubMed ID: 33652066
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia.
    Vergouwen MD; Vermeulen M; Coert BA; Stroes ES; Roos YB
    J Cereb Blood Flow Metab; 2008 Nov; 28(11):1761-70. PubMed ID: 18628782
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of neurological complications related to aneurysmal subarachnoid hemorrhage: A comparison of the bedside therapeutic algorithms.
    Solou M; Ydreos I; Papadopoulos EK; Demetriades AK; Boviatsis EJ
    Surgeon; 2023 Dec; 21(6):e328-e345. PubMed ID: 37451887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Age-Dependent Radiographic Vasospasm and Delayed Cerebral Ischemia in Women After Aneurysmal Subarachnoid Hemorrhage.
    Lai PMR; Gormley WB; Patel N; Frerichs KU; Aziz-Sultan MA; Du R
    World Neurosurg; 2019 Oct; 130():e230-e235. PubMed ID: 31203057
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spreading depolarization-modulating drugs and delayed cerebral ischemia after subarachnoid hemorrhage: A hypothesis-generating retrospective clinical study.
    Hamming AM; Mulder IA; Gathier CS; van den Bergh WM; Dankbaar JW; Hoff RG; Vandertop WP; Verbaan D; Ferrari MD; Rinkel GJE; Algra A; Wermer MJH
    J Neurol Sci; 2016 Jul; 366():224-228. PubMed ID: 27288811
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. Clinical article.
    Tseng MY; Hutchinson PJ; Richards HK; Czosnyka M; Pickard JD; Erber WN; Brown S; Kirkpatrick PJ
    J Neurosurg; 2009 Jul; 111(1):171-80. PubMed ID: 19344224
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of intrathecal milrinone injection via lumbar catheter on delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Koyanagi M; Fukuda H; Lo B; Uezato M; Kurosaki Y; Sadamasa N; Handa A; Chin M; Yamagata S
    J Neurosurg; 2018 Mar; 128(3):717-722. PubMed ID: 28298035
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An introduction to the pathophysiology of aneurysmal subarachnoid hemorrhage.
    van Lieshout JH; Dibué-Adjei M; Cornelius JF; Slotty PJ; Schneider T; Restin T; Boogaarts HD; Steiger HJ; Petridis AK; Kamp MA
    Neurosurg Rev; 2018 Oct; 41(4):917-930. PubMed ID: 28215029
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of fasudil hydrochloride, a protein kinase inhibitor, on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage.
    Zhao J; Zhou D; Guo J; Ren Z; Zhou L; Wang S; Xu B; Wang R
    Neurol Med Chir (Tokyo); 2006 Sep; 46(9):421-8. PubMed ID: 16998274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Impact of Nimodipine Administration through Feeding Tube on Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage.
    Isse FA; Abdallah YEH; Mahmoud SH
    J Pharm Pharm Sci; 2020; 23(1):100-108. PubMed ID: 32348716
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Brain Oxygen-Directed Management of Aneurysmal Subarachnoid Hemorrhage. Temporal Patterns of Cerebral Ischemia During Acute Brain Attack, Early Brain Injury, and Territorial Sonographic Vasospasm.
    Narotam PK; Garton A; Morrison J; Nathoo N; Narotam N
    World Neurosurg; 2022 Oct; 166():e215-e236. PubMed ID: 35803565
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Significance of fluctuations in serum sodium levels following aneurysmal subarachnoid hemorrhage: an exploratory analysis.
    Eagles ME; Tso MK; Macdonald RL
    J Neurosurg; 2018 Aug; 131(2):420-425. PubMed ID: 30117765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.